Molecular Biomarkers Market Report

Europe Molecular Biomarkers Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 11, 2020
  • PAGES：213
  • REPORT CODE：GMM503565
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Molecular Biomarkers market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Molecular Biomarkers Market Segmentations:

    By Player:

    • GenomeDx

    • Genomic Health

    • Biophysical

    • PGD

    • Molecular Response

    • Nodality

    • Gen-Probe

    • Genomic Health

    • Epic Sciences

    • Alere

    • Foundation Medicine

    • Life Technologies

    • BioTheranostics

    • Cynvenio

    • Nodality

    • Abbott

    • Atossa Genetics

    • 20/20 GeneSystems

    • BioCept

    • Dako (Agilent)

    By Type:

    • Genomics

    • Proteomics

    • Others

    By End-User:

    • Medicine

    • Biology

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Molecular Biomarkers Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Molecular Biomarkers Market Size and Growth Rate of Genomics from 2014 to 2026

    • 1.3.2 Europe Molecular Biomarkers Market Size and Growth Rate of Proteomics from 2014 to 2026

    • 1.3.3 Europe Molecular Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Molecular Biomarkers Market Size and Growth Rate of Medicine from 2014 to 2026

    • 1.4.2 Europe Molecular Biomarkers Market Size and Growth Rate of Biology from 2014 to 2026

    • 1.4.3 Europe Molecular Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Molecular Biomarkers Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Molecular Biomarkers by Major Types

      • 3.4.1 Market Size and Growth Rate of Genomics

      • 3.4.2 Market Size and Growth Rate of Proteomics

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Molecular Biomarkers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Molecular Biomarkers by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Molecular Biomarkers for Medicine

      • 4.4.2 Market Size and Growth Rate of Molecular Biomarkers for Biology

      • 4.4.3 Market Size and Growth Rate of Molecular Biomarkers for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Molecular Biomarkers Production Analysis by Top Regions

    • 5.2 Europe Molecular Biomarkers Consumption Analysis by Top Regions

    • 5.3 Europe Molecular Biomarkers Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.3 France Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Production, Import, Consumption and Export Analysis

    6 Product Circulation of Molecular Biomarkers Market among Top Countries

    • 6.1 Top 5 Export Countries in Molecular Biomarkers Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Molecular Biomarkers Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Molecular Biomarkers Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Molecular Biomarkers Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Molecular Biomarkers Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Molecular Biomarkers Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Molecular Biomarkers Landscape Analysis

    • 7.1 Germany Molecular Biomarkers Landscape Analysis by Major Types

    • 7.2 Germany Molecular Biomarkers Landscape Analysis by Major End-Users

    8. UK Molecular Biomarkers Landscape Analysis

    • 8.1 UK Molecular Biomarkers Landscape Analysis by Major Types

    • 8.2 UK Molecular Biomarkers Landscape Analysis by Major End-Users

    9. France Molecular Biomarkers Landscape Analysis

    • 9.1 France Molecular Biomarkers Landscape Analysis by Major Types

    • 9.2 France Molecular Biomarkers Landscape Analysis by Major End-Users

    10. Italy Molecular Biomarkers Landscape Analysis

    • 10.1 Italy Molecular Biomarkers Landscape Analysis by Major Types

    • 10.2 Italy Molecular Biomarkers Landscape Analysis by Major End-Users

    11. Spain Molecular Biomarkers Landscape Analysis

    • 11.1 Spain Molecular Biomarkers Landscape Analysis by Major Types

    • 11.2 Spain Molecular Biomarkers Landscape Analysis by Major End-Users

    12. Poland Molecular Biomarkers Landscape Analysis

    • 12.1 Poland Molecular Biomarkers Landscape Analysis by Major Types

    • 12.2 Poland Molecular Biomarkers Landscape Analysis by Major End-Users

    13. Russia Molecular Biomarkers Landscape Analysis

    • 13.1 Russia Molecular Biomarkers Landscape Analysis by Major Types

    • 13.2 Russia Molecular Biomarkers Landscape Analysis by Major End-Users

    14. Switzerland Molecular Biomarkers Landscape Analysis

    • 14.1 Switzerland Molecular Biomarkers Landscape Analysis by Major Types

    • 14.2 Switzerland Molecular Biomarkers Landscape Analysis by Major End-Users

    15. Turkey Molecular Biomarkers Landscape Analysis

    • 15.1 Turkey Molecular Biomarkers Landscape Analysis by Major Types

    • 15.2 Turkey Molecular Biomarkers Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Landscape Analysis by Top Countries

      • 16.3.1 Denmark Molecular Biomarkers Market Volume and Growth Rate

      • 16.3.2 Finland Molecular Biomarkers Market Volume and Growth Rate

      • 16.3.3 Norway Molecular Biomarkers Market Volume and Growth Rate

      • 16.3.4 Sweden Molecular Biomarkers Market Volume and Growth Rate

      • 16.3.6 Iceland Molecular Biomarkers Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Landscape Analysis by Top Countries

      • 17.3.1 Belgium Molecular Biomarkers Market Volume and Growth Rate

      • 17.3.2 Netherlands Molecular Biomarkers Market Volume and Growth Rate

      • 17.3.3 Luxembourg Molecular Biomarkers Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Landscape Analysis by Top Countries

      • 18.3.1 Estonia Molecular Biomarkers Market Volume and Growth Rate

      • 18.3.2 Latvia Molecular Biomarkers Market Volume and Growth Rate

      • 18.3.3 Lithuania Molecular Biomarkers Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GenomeDx

      • 19.1.1 GenomeDx Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Genomic Health

      • 19.2.1 Genomic Health Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Biophysical

      • 19.3.1 Biophysical Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 PGD

      • 19.4.1 PGD Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Molecular Response

      • 19.5.1 Molecular Response Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Nodality

      • 19.6.1 Nodality Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Gen-Probe

      • 19.7.1 Gen-Probe Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Genomic Health

      • 19.8.1 Genomic Health Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Epic Sciences

      • 19.9.1 Epic Sciences Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Alere

      • 19.10.1 Alere Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Foundation Medicine

      • 19.11.1 Foundation Medicine Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Life Technologies

      • 19.12.1 Life Technologies Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 BioTheranostics

      • 19.13.1 BioTheranostics Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Cynvenio

      • 19.14.1 Cynvenio Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Nodality

      • 19.15.1 Nodality Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Abbott

      • 19.16.1 Abbott Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Atossa Genetics

      • 19.17.1 Atossa Genetics Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 20/20 GeneSystems

      • 19.18.1 20/20 GeneSystems Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 BioCept

      • 19.19.1 BioCept Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Dako (Agilent)

      • 19.20.1 Dako (Agilent) Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 89 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Genomics from 2014 to 2026

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Proteomics from 2014 to 2026

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Medicine from 2014 to 2026

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Biology from 2014 to 2026

    • Figure Europe Molecular Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure UK Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure France Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Molecular Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Molecular Biomarkers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Molecular Biomarkers

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Molecular Biomarkers by Different Types from 2014 to 2026

    • Table Consumption Share of Molecular Biomarkers by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Genomics

    • Figure Market Size and Growth Rate of Proteomics

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Molecular Biomarkers by Different End-Users from 2014 to 2026

    • Table Consumption Share of Molecular Biomarkers by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medicine

    • Figure Market Size and Growth Rate of Biology

    • Figure Market Size and Growth Rate of Others

    • Table Europe Molecular Biomarkers Production by Major Regions

    • Table Europe Molecular Biomarkers Production Share by Major Regions

    • Figure Europe Molecular Biomarkers Production Share by Major Countries and Regions in 2014

    • Table Europe Molecular Biomarkers Consumption by Major Regions

    • Table Europe Molecular Biomarkers Consumption Share by Major Regions

    • Table Germany Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table UK Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table France Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Italy Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Spain Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Poland Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Russia Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Switzerland Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Turkey Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Molecular Biomarkers Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Molecular Biomarkers Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Molecular Biomarkers Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Molecular Biomarkers Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Germany Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Germany Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Germany Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table UK Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table UK Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table UK Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table UK Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table France Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table France Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table France Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table France Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Italy Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Italy Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Italy Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Italy Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Spain Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Spain Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Spain Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Spain Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Poland Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Poland Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Poland Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Poland Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Russia Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Russia Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Russia Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Russia Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Switzerland Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Switzerland Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Switzerland Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Turkey Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Turkey Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Turkey Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Molecular Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GenomeDx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenomeDx

    • Figure Sales and Growth Rate Analysis of GenomeDx

    • Figure Revenue and Market Share Analysis of GenomeDx

    • Table Product and Service Introduction of GenomeDx

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Biophysical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biophysical

    • Figure Sales and Growth Rate Analysis of Biophysical

    • Figure Revenue and Market Share Analysis of Biophysical

    • Table Product and Service Introduction of Biophysical

    • Table Company Profile and Development Status of PGD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PGD

    • Figure Sales and Growth Rate Analysis of PGD

    • Figure Revenue and Market Share Analysis of PGD

    • Table Product and Service Introduction of PGD

    • Table Company Profile and Development Status of Molecular Response

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Response

    • Figure Sales and Growth Rate Analysis of Molecular Response

    • Figure Revenue and Market Share Analysis of Molecular Response

    • Table Product and Service Introduction of Molecular Response

    • Table Company Profile and Development Status of Nodality

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nodality

    • Figure Sales and Growth Rate Analysis of Nodality

    • Figure Revenue and Market Share Analysis of Nodality

    • Table Product and Service Introduction of Nodality

    • Table Company Profile and Development Status of Gen-Probe

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gen-Probe

    • Figure Sales and Growth Rate Analysis of Gen-Probe

    • Figure Revenue and Market Share Analysis of Gen-Probe

    • Table Product and Service Introduction of Gen-Probe

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Epic Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epic Sciences

    • Figure Sales and Growth Rate Analysis of Epic Sciences

    • Figure Revenue and Market Share Analysis of Epic Sciences

    • Table Product and Service Introduction of Epic Sciences

    • Table Company Profile and Development Status of Alere

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere

    • Figure Sales and Growth Rate Analysis of Alere

    • Figure Revenue and Market Share Analysis of Alere

    • Table Product and Service Introduction of Alere

    • Table Company Profile and Development Status of Foundation Medicine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Foundation Medicine

    • Figure Sales and Growth Rate Analysis of Foundation Medicine

    • Figure Revenue and Market Share Analysis of Foundation Medicine

    • Table Product and Service Introduction of Foundation Medicine

    • Table Company Profile and Development Status of Life Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Life Technologies

    • Figure Sales and Growth Rate Analysis of Life Technologies

    • Figure Revenue and Market Share Analysis of Life Technologies

    • Table Product and Service Introduction of Life Technologies

    • Table Company Profile and Development Status of BioTheranostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTheranostics

    • Figure Sales and Growth Rate Analysis of BioTheranostics

    • Figure Revenue and Market Share Analysis of BioTheranostics

    • Table Product and Service Introduction of BioTheranostics

    • Table Company Profile and Development Status of Cynvenio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cynvenio

    • Figure Sales and Growth Rate Analysis of Cynvenio

    • Figure Revenue and Market Share Analysis of Cynvenio

    • Table Product and Service Introduction of Cynvenio

    • Table Company Profile and Development Status of Nodality

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nodality

    • Figure Sales and Growth Rate Analysis of Nodality

    • Figure Revenue and Market Share Analysis of Nodality

    • Table Product and Service Introduction of Nodality

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Atossa Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Atossa Genetics

    • Figure Sales and Growth Rate Analysis of Atossa Genetics

    • Figure Revenue and Market Share Analysis of Atossa Genetics

    • Table Product and Service Introduction of Atossa Genetics

    • Table Company Profile and Development Status of 20/20 GeneSystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 20/20 GeneSystems

    • Figure Sales and Growth Rate Analysis of 20/20 GeneSystems

    • Figure Revenue and Market Share Analysis of 20/20 GeneSystems

    • Table Product and Service Introduction of 20/20 GeneSystems

    • Table Company Profile and Development Status of BioCept

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCept

    • Figure Sales and Growth Rate Analysis of BioCept

    • Figure Revenue and Market Share Analysis of BioCept

    • Table Product and Service Introduction of BioCept

    • Table Company Profile and Development Status of Dako (Agilent)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dako (Agilent)

    • Figure Sales and Growth Rate Analysis of Dako (Agilent)

    • Figure Revenue and Market Share Analysis of Dako (Agilent)

    • Table Product and Service Introduction of Dako (Agilent)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US